Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study

INTRODUCTION: Individual variability of rivaroxaban was observed in clinical application. This study aimed to identify genetic variants associated with the variability of pharmacodynamics and bleeding risk of rivaroxbaban in patients with nonvalvular atrial fibrillation (NVAF). MATERIALS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Qian, Wang, Zhe, Mu, Guangyan, Xie, Qiufen, Liu, Zhiyan, Zhou, Shuang, Zhang, Hanxu, Wang, Zining, Jiang, Jie, Hu, Kun, Zhang, Yatong, Zhao, Zinan, Yuan, Dongdong, Guo, Liping, Wu, Tingting, Zhang, Jinhua, Wang, Na, Xiang, Jing, Gu, Zhichun, Sun, Jianjun, Cui, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196221/
https://www.ncbi.nlm.nih.gov/pubmed/37203300
http://dx.doi.org/10.1002/ctm2.1263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196221/
https://www.ncbi.nlm.nih.gov/pubmed/37203300
http://dx.doi.org/10.1002/ctm2.1263

Ejemplares similares